Evidence map›Paper›PMID 25122767›Full record

ArticleThe Journal of biological chemistry2014

Hyaluronan breakdown contributes to immune defense against group A Streptococcus.

Nina N Schommer, Jun Muto, Victor Nizet, Richard L Gallo

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. The Role ofInternational journal of molecular sciences · 2025
    Review
  2. Review
  3. Effect of Glycosaminoglycans onApplied and environmental microbiology · 2023
    Article
  4. Review
  5. Article
  6. Microorganisms · 2021
    Review
  7. The Role of Glycosylation in Infectious Diseases.Advances in experimental medicine and biology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Group AMicrobiology spectrum · 2019
    Article
  13. Glycointeractions in bacterial pathogenesis.Nature reviews. Microbiology · 2018
    Review
  14. The consequence of matrix dysfunction on lung immunity and the microbiome in COPD.European respiratory review : an official journal of the European Respiratory Society · 2018
    Article
  15. Review
  16. Article
  17. Glycosaminoglycans and infection.Frontiers in bioscience (Landmark edition) · 2016
    Review
  18. Review
  19. Article
  20. Molecular and genomic characterization of pathogenic traits of group A Streptococcus pyogenes.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nina N SchommerDivision of Dermatology, Department of Medicine, University of California, San Diego, La Jolla, California 92093.
Jun MutoDivision of Dermatology, Department of Medicine, University of California, San Diego, La Jolla, California 92093.
Victor NizetDivision of Pharmacology and Drug Discovery, Department of Pediatrics, and University of California, San Diego, La Jolla, California 92093; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093.
Richard L GalloDivision of Dermatology, Department of Medicine, University of California, San Diego, La Jolla, California 92093; Division of Pharmacology and Drug Discovery, Department of Pediatrics, and University of California, San Diego, La Jolla, California 92093. Electronic address: rgallo@ucsd.edu.
University of California, San Diego · USUniversity of Montana · US

Funding

Siglec Modulation of Inflammation in Humans and MiceP01HL057345 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARKI, NISSI MARY · 1997 to 2012
$24.1M
Siglec Modulation of Inflammatory ResponsesP01HL107150 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LE, DZUNG T · 2011 to 2017
$18.0M
GAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8M
Skin Microbiome in epidermal immune defenseR01AI083358 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GALLO, RICHARD L · 2010 to 2014
$1.9M
NHLBI NIH HHS P01 HL057345NHLBI NIH HHS P01HL057345NHLBI NIH HHS P01 HL107150NHLBI NIH HHS P01HL107150NIAID NIH HHS R01 AI077780NIAID NIH HHS R01 AI083358
6 · The paper itself

Abstract

Group A Streptococcus (GAS) commonly infects human skin and occasionally causes severe and life-threatening invasive diseases. The hyaluronan (HA) capsule of GAS has been proposed to protect GAS from host defense by mimicking endogenous HA, a large and abundant glycosaminoglycan in the skin. However, HA is degraded during tissue injury, and the functions of short-chain HA that is generated during infection have not been studied. To examine the impact of the molecular mass of HA on GAS infection, we established infection models in vitro and in vivo in which the size of HA was defined by enzymatic digestion or custom synthesis. We discovered that conversion of high molecular mass HA to low molecular mass HA facilitated GAS phagocytosis by macrophages and limited the severity of infection in mice. In contrast, native high molecular mass HA significantly impaired internalization by macrophages and increased GAS survival in murine blood. Thus, our data demonstrate that GAS virulence can be influenced by the size of HA derived from both the bacterium and host and suggest that high molecular mass HA facilitates GAS deep tissue infections, whereas the generation of short-chain HA can be protective.

Indexed as

PhagocytosisAnimalsBacterial CapsulesCell LineHumansHyaluronic AcidMacrophagesMiceMice, TransgenicSkin Diseases, BacterialStreptococcal InfectionsStreptococcus pyogenesHyaluronic AcidHyaluronanHyaluronidaseInnate ImmunitySkinStreptococcus pyogenes (S. pyogenes)

Identifiers

PMID25122767
PMCPMC4175332
OpenAlexW2108383175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.